AbbVie to Host First-Quarter 2025 Earnings Conference Call
Get Alerts ABBV Hot Sheet
Join SI Premium – FREE
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology, neuroscience and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter) and YouTube.
Media: | Investors: |
Gabby Tarbert | |
(224) 244-0111 | (847) 935-2211 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-to-host-first-quarter-2025-earnings-conference-call-302414655.html
SOURCE AbbVie
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Abbvie (ABBV) PT Raised to $288 at Guggenheim
- SHINE Selected for Two DOE Genesis Mission Projects Advancing AI in Nuclear Fuel Recycling
- IsoEnergy and DISA Technologies to Form DISA Uranium Corporation, Creating a Technology-Enabled U.S. Uranium Platform for Production, Processing, and Remediation
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Twitter, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share